Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'OXIDATIVE DRUG-METABOLISM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 135 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Guengerich, FP
      Forging the links between metabolism and carcinogenesis

      MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
    2. Dixit, RK; Chawla, AB; Kumar, N; Garg, SK
      Effect of omeprazole on the pharmacokinetics of sustained-release carbamazepine in healthy male volunteers

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    3. Calafatti, SA; Ortiz, RAM; Deguer, M; Martinez, M; Pedrazzoli, J
      Effect of acid secretion blockade by omeprazole on the relative bioavailability of orally administered furazolidone in healthy volunteers

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    4. Venkatakrishnan, K; Schmider, J; Harmatz, JS; Ehrenberg, BL; von Moltke, LL; Graf, JA; Mertzanis, P; Corbett, KE; Rodriguez, MC; Shader, RI; Greenblatt, DJ
      Relative contribution of CYP3A to amitriptyline clearance in humans: In vitro and in vivo studies

      JOURNAL OF CLINICAL PHARMACOLOGY
    5. Chun, YJ; Ryu, SY; Jeong, TC; Kim, MY
      Mechanism-based inhibition of human cytochrome p450 1A1 by rhapontigenin

      DRUG METABOLISM AND DISPOSITION
    6. Yamazaki, H; Shimada, T; Martin, MV; Guengerich, FP
      Stimulation of cytochrome P450 reactions by apo-cytochrome b(5) - Evidenceagainst transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5, orheme oxygenase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    7. Klotz, U
      Pharmacokinetic considerations in the eradication of Helicobacter pylori

      CLINICAL PHARMACOKINETICS
    8. van Miert, ASJPAM
      Trends in veterinary clinical and fundamental pharmacology: Past and future in the Netherlands

      VETERINARY QUARTERLY
    9. Stowe, CD; Lee, KR; Storgion, SA; Phelps, SJ
      Altered phenytoin pharmacokinetics in children with severe, acute traumatic brain injury

      JOURNAL OF CLINICAL PHARMACOLOGY
    10. Hosea, NA; Miller, GP; Guengerich, FP
      Elucidation of distinct ligand binding sites for cytochrome P450 3A4

      BIOCHEMISTRY
    11. Hanna, IH; Reed, JR; Guengerich, FP; Hollenberg, PF
      Expression of human cytochrome P4502B6 in Escherichia coli: Characterization of catalytic activity and expression levels in human liver

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    12. Chida, M; Yokoi, T; Kosaka, Y; Chiba, K; Nakamura, H; Ishizaki, T; Yokota, J; Kinoshita, M; Sato, K; Inaba, M; Aoki, Y; Gonzalez, FJ; Kamataki, T
      Genetic polymorphism of CYP2D6 in the Japanese population

      PHARMACOGENETICS
    13. Scott, RJ; Palmer, J; Lewis, IAS; Pleasance, S
      Determination of a 'GW cocktail' of cytochrome P450 probe substrates and their metabolites in plasma and urine using automated solid phase extractionand fast gradient liquid chromatography tandem mass spectrometry

      RAPID COMMUNICATIONS IN MASS SPECTROMETRY
    14. Rost, KL; Fuhr, U; Thomsen, T; Zaigler, M; Brockmoller, J; Bohnemeier, H; Roots, I
      Omeprazole weakly inhibits CYP1A2 activity in man

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    15. Desille, M; Corcos, L; L'Helgoualc'h, A; Fremond, B; Campion, JP; Guillouzo, A; Clement, B
      Detoxifying activity in pig livers and hepatocytes intended for xenotherapy

      TRANSPLANTATION
    16. Soucek, P
      Cytochrome P450 destruction by quinones: Comparison of effects in rat and human liver microsomes

      CHEMICO-BIOLOGICAL INTERACTIONS
    17. Yun, CH; Ahn, T; Guengerich, FP; Yamazaki, H; Shimada, T
      Phospholipase D activity of cytochrome P450 in human liver endoplasmic reticulum

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    18. BOUCHER BA; HANES SD
      PHARMACOKINETIC ALTERATIONS AFTER SEVERE HEAD-INJURY - CLINICAL RELEVANCE

      Clinical pharmacokinetics
    19. DAVID FL; DASILVA CMF; MENDES FD; FERRAZ JGP; MUSCARA MN; MORENO H; DENUCCI G; PEDRAZZOLI J
      ACID SUPPRESSION BY OMEPRAZOLE DOES NOT AFFECT ORALLY-ADMINISTERED METRONIDAZOLE BIOAVAILABILITY AND METABOLISM IN HEALTHY MALE-VOLUNTEERS

      Alimentary pharmacology & therapeutics
    20. NIWA T; YABUSAKI Y; HONMA K; MATSUO N; TATSUTA K; ISHIBASHI F; KATAGIRI M
      CONTRIBUTION OF HUMAN HEPATIC CYTOCHROME-P450 ISOFORMS TO REGIOSELECTIVE HYDROXYLATION OF STEROID-HORMONES

      Xenobiotica
    21. KAMIMURA H; OISHI S; MATSUSHIMA H; WATANABE T; HIGUCHI S; HALL M; WOOD SG; CHASSEAUD LF
      IDENTIFICATION OF CYTOCHROME-P450 ISOZYMES INVOLVED IN METABOLISM OF THE ALPHA(1)-ADRENOCEPTOR BLOCKER TAMSULOSIN IN HUMAN LIVER-MICROSOMES

      Xenobiotica (London. Print)
    22. CHESNE C; GUYOMARD C; GUILLOUZO A; SCHMID J; LUDWIG E; SAUTER T
      METABOLISM OF MELOXICAM IN HUMAN LIVER INVOLVES CYTOCHROMES P4502C9 AND 3A4

      Xenobiotica
    23. Smith, G; Stubbins, MJ; Harries, LW; Wolf, CR
      Molecular genetics of the human cytochrome P450 monooxygenase superfamily

      XENOBIOTICA
    24. Clarke, SE
      In vitro assessment of human cytochrome P450

      XENOBIOTICA
    25. Pelkonen, O; Maenpaa, J; Taavitsainen, P; Rautio, A; Raunio, H
      Inhibition and induction of human cytochrome P450 (CYP) enzymes

      XENOBIOTICA
    26. BROCKMEYER NH; BARTHEL B; MERTINS L; GOOS M
      EFFECT OF ZIDOVUDINE THERAPY IN PATIENTS WITH HIV-INFECTION ON ENDOGENOUS INTERFERON PLASMA-LEVELS AND THE HEPATIC CYTOCHROME-P450 ENZYME-SYSTEM

      Chemotherapy
    27. LASKER JM; WESTER MR; ARAMSOMBATDEE E; RAUCY JL
      CHARACTERIZATION OF CYP2C19 AND CYP2C9 FROM HUMAN LIVER - RESPECTIVE ROLES IN MICROSOMAL TOLBUTAMIDE, S-MEPHENYTOIN, AND OMEPRAZOLE HYDROXYLATIONS

      Archives of biochemistry and biophysics
    28. PARIKH A; GUENGERICH FP
      EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF A CATALYTICALLY ACTIVE HUMAN CYTOCHROME-P450 1A2-RAT NADPH-CYTOCHROME P450 REDUCTASE FUSION PROTEIN

      Protein expression and purification
    29. BERTZ RJ; GRANNEMAN GR
      USE OF IN-VITRO AND IN-VIVO DATA TO ESTIMATE THE LIKELIHOOD OF METABOLIC PHARMACOKINETIC INTERACTIONS

      Clinical pharmacokinetics
    30. SYVALAHTI EKG; TAIMINEN T; SAARIJARVI S; LEHTO H; NIEMI H; AHOLA V; DAHL ML; SALOKANGAS RKR
      CITALOPRAM CAUSES NO SIGNIFICANT ALTERATIONS IN PLASMA NEUROLEPTIC LEVELS IN SCHIZOPHRENIC-PATIENTS

      Journal of international medical research
    31. TOLMAN KG; SANDERS SW; BUCHI KN; KAROL MD; JENNINGS DE; RINGHAM GL
      THE EFFECTS OF ORAL DOSES OF LANSOPRAZOLE AND OMEPRAZOLE ON GASTRIC PH

      Journal of clinical gastroenterology
    32. OMAR G; WHITING PH; HAWKSWORTH GM; HUMPHREY MJ; BURKE MD
      KETOCONAZOLE AND FLUCONAZOLE INHIBITION OF THE METABOLISM OF CYCLOSPORINE-A BY HUMAN LIVER IN-VITRO

      Therapeutic drug monitoring
    33. ANDERSON KE; HAMMONS GJ; KADLUBAR FF; POTTER JD; KADERLIK KR; ILETT KF; MINCHIN RF; TEITEL CH; CHOU HC; MARTIN MV; GUENGERICH FP; BARONE GW; LANG NP; PETERSON LA
      METABOLIC-ACTIVATION OF AROMATIC-AMINES BY HUMAN PANCREAS

      Carcinogenesis
    34. KO JW; SUKHOVA N; THACKER D; CHEN P; FLOCKHART DA
      EVALUATION OF OMEPRAZOLE AND LANSOPRAZOLE AS INHIBITORS OF CYTOCHROME-P450 ISOFORMS

      Drug metabolism and disposition
    35. YAMAZAKI H; INOUE K; TURVY CG; GUENGERICH FP; SHIMADA T
      EFFECTS OF FREEZING, THAWING, AND STORAGE OF HUMAN LIVER SAMPLES ON THE MICROSOMAL CONTENTS AND ACTIVITIES OF CYTOCHROME-P450 ENZYMES

      Drug metabolism and disposition
    36. ZOMORODI K; HOUSTON JB
      SELECTIVITY OF OMEPRAZOLE INHIBITION TOWARDS RAT-LIVER CYTOCHROMES P450

      Xenobiotica
    37. KOBAYASHI K; CHIBA K; YAGI T; SHIMADA N; TANIGUCHI T; HORIE T; TANI M; YAMAMOTO T; ISHIZAKI T; KUROIWA Y
      IDENTIFICATION OF CYTOCHROME-P450 ISOFORMS INVOLVED IN CITALOPRAM N-DEMETHYLATION BY HUMAN LIVER-MICROSOMES

      The Journal of pharmacology and experimental therapeutics
    38. LINDER MW; PROUGH RA; VALDES R
      PHARMACOGENETICS - A LABORATORY TOOL FOR OPTIMIZING THERAPEUTIC EFFICIENCY

      Clinical chemistry
    39. GUENGERICH FP
      COMPARISONS OF CATALYTIC SELECTIVITY OF CYTOCHROME-P450 SUBFAMILY ENZYMES FROM DIFFERENT SPECIES

      Chemico-biological interactions
    40. GUENGERICH FP; JOHNSON WW
      KINETICS OF FERRIC CYTOCHROME-P450 REDUCTION BY NADPH-CYTOCHROME P450REDUCTASE - RAPID REDUCTION IN THE ABSENCE OF SUBSTRATE AND VARIATIONS AMONG CYTOCHROME-P450 SYSTEMS

      Biochemistry
    41. YAMAZAKI H; SHIMADA T
      HUMAN LIVER CYTOCHROME-P450 ENZYMES INVOLVED IN THE 7-HYDROXYLATION OF R-WARFARIN AND S-WARFARIN ENANTIOMERS

      Biochemical pharmacology
    42. YAMAZAKI H; GILLAM EMJ; DONG MS; JOHNSON WW; GUENGERICH FP; SHIMADA T
      RECONSTITUTION OF RECOMBINANT CYTOCHROME-P450 2C10(2C9) AND COMPARISON WITH CYTOCHROME-P450 3A4 AND OTHER FORMS - EFFECTS OF CYTOCHROME P450-P450 AND CYTOCHROME P450-B(5) INTERACTIONS

      Archives of biochemistry and biophysics
    43. GOLDBERG RJ
      THE P-450 SYSTEM - DEFINITION AND RELEVANCE TO THE USE OF ANTIDEPRESSANTS IN MEDICAL-PRACTICE

      Archives of family medicine
    44. BLIESATH H; HUBER R; STEINIJANS VW; KOCH HJ; KUNZ K; WURST W
      PANTOPRAZOLE DOES NOT INTERACT WITH NIFEDIPINE IN MAN UNDER STEADY-STATE CONDITIONS

      International journal of clinical pharmacology and therapeutics
    45. DEMEY C; MEINEKE I; STEINIJANS VW; HUBER R; HARTMANN M; BLIESATH H; WURST W
      PANTOPRAZOLE LACKS INTERACTION WITH ANTIPYRINE IN MAN, EITHER BY INHIBITION OR INDUCTION

      International journal of clinical pharmacology and therapeutics
    46. BLIESATH H; HUBER R; STEINIJANS VW; KOCH HJ; KUNZ K; WURST W
      PANTOPRAZOLE DOES NOT INTERACT WITH NIFEDIPINE IN MAN UNDER STEADY-STATE CONDITIONS

      International journal of clinical pharmacology and therapeutics
    47. CAVANAUGH JH; KAROL MD
      LACK OF PHARMACOKINETIC INTERACTION AFTER ADMINISTRATION OF LANSOPRAZOLE OR OMEPRAZOLE WITH PREDNISONE

      Journal of clinical pharmacology
    48. HEYN H; WHITE RB; STEVENS JC
      CATALYTIC ROLE OF CYTOCHROME P4502B6 IN THE N-DEMETHYLATION OF S-MEPHENYTOIN

      Drug metabolism and disposition
    49. CARACO Y; TATEISHI T; GUENGERICH FP; WOOD AJJ
      MICROSOMAL CODEINE N-DEMETHYLATION - COSEGREGATION WITH CYTOCHROME P45O3A4 ACTIVITY

      Drug metabolism and disposition
    50. JIANG QS; HUANG YJ; VOIGT JM; DEBOLT BK; KOMINAMI S; TAKEMORI S; FUNAE Y; COLBY HD
      EXPRESSION AND ZONAL DISTRIBUTION OF CYP2D16 IN THE GUINEA-PIG ADRENAL-CORTEX - RELATIONSHIP TO XENOBIOTIC METABOLISM

      Molecular pharmacology
    51. ZHAO XJ; YOKOYAMA H; CHIBA K; WANWIMOLRUK S; ISHIZAKI T
      IDENTIFICATION OF HUMAN CYTOCHROME-P450 ISOFORMS INVOLVED IN THE 3-HYDROXYLATION OF QUININE BY HUMAN LIVER-MICROSOMES AND 9 RECOMBINANT HUMAN CYTOCHROMES P450

      The Journal of pharmacology and experimental therapeutics
    52. PEARCE RE; RODRIGUES AD; GOLDSTEIN JA; PARKINSON A
      IDENTIFICATION OF THE HUMAN P450 ENZYMES INVOLVED IN LANSOPRAZOLE METABOLISM

      The Journal of pharmacology and experimental therapeutics
    53. BOURRIE M; MEUNIER V; BERGER Y; FABRE G
      CYTOCHROME-P450 ISOFORM INHIBITORS AS A TOOL FOR THE INVESTIGATION OFMETABOLIC REACTIONS CATALYZED BY HUMAN LIVER-MICROSOMES

      The Journal of pharmacology and experimental therapeutics
    54. YAMAZAKI H; JOHNSON WW; UENG YF; SHIMADA T; GUENGERICH FP
      LACK OF ELECTRON-TRANSFER FROM CYTOCHROME B(5) IN STIMULATION OF CATALYTIC ACTIVITIES OF CYTOCHROME-P450 3A4 - CHARACTERIZATION OF A RECONSTITUTED CYTOCHROME-P450 3A4 NADPH-CYTOCHROME P450 REDUCTASE SYSTEM ANDSTUDIES WITH APO-CYTOCHROME B(5)

      The Journal of biological chemistry
    55. CARACO Y; WILKINSON GR; WOOD AJJ
      DIFFERENCES BETWEEN WHITE SUBJECTS AND CHINESE SUBJECTS IN THE IN-VIVO INHIBITION OF CYTOCHROME P450S 2C19, 2D6, AND 3A BY OMEPRAZOLE

      Clinical pharmacology and therapeutics
    56. HUANG YJ; JIANG QS; VOIGT JM; DEBOLT KM; COLBY HD
      STRAIN DIFFERENCES IN ADRENAL CYP2D16 EXPRESSION IN GUINEA-PIGS - RELATIONSHIP TO XENOBIOTIC METABOLISM

      Biochemical pharmacology
    57. ROOS PH; MAHNKE A
      METABOLITE COMPLEX-FORMATION OF ORPHENADRINE WITH CYTOCHROME-P450 - INVOLVEMENT OF CYP2C11 AND CYP3A ISOZYMES

      Biochemical pharmacology
    58. IMAOKA S; YAMADA T; HIROI T; HAYASHI K; SAKAKI T; YABUSAKI Y; FUNAE Y
      MULTIPLE FORMS OF HUMAN P450 EXPRESSED IN SACCHAROMYCES-CEREVISIAE

      Biochemical pharmacology
    59. CHUN YJ; SHIMADA T; GUENGERICH FP
      CONSTRUCTION OF A HUMAN CYTOCHROME-P450 1A1-RAT NADPH-CYTOCHROME P450REDUCTASE FUSION PROTEIN CDNA AND EXPRESSION IN ESCHERICHIA-COLI, PURIFICATION, AND CATALYTIC PROPERTIES OF THE ENZYME IN BACTERIAL-CELLS AND AFTER PURIFICATION

      Archives of biochemistry and biophysics
    60. DONG MS; YAMAZAKI H; GUO ZY; GUENGERICH FP
      RECOMBINANT HUMAN CYTOCHROME-P450 1A2 AND AN N-TERMINAL-TRUNCATED FORM - CONSTRUCTION, PURIFICATION, AGGREGATION PROPERTIES, AND INTERACTIONS WITH FLAVODOXIN,FERREDOXIN, AND NADPH-CYTOCHROME P450 REDUCTASE

      Archives of biochemistry and biophysics
    61. JANUS K; MUSZCZYNSKI Z; SKRZYPCZAK WF
      HEPATIC BIOTRANSFORMATION RATE IN CALVES FED FOOD RATIONS WITH PROTEIN OR CARBOHYDRATE SUPPLEMENTS

      ACTA VETERINARIA BRNO
    62. EVANS DAP; KRAHN P; NARAYANAN N
      THE MEPHENYTOIN (CYTOCHROME-P450 2C-19) AND DEXTROMETHORPHAN (CYTOCHROME-P450 2D6) POLYMORPHISMS IN SAUDI-ARABIANS AND FILIPINOS

      Pharmacogenetics
    63. WERNER M; GUO ZY; BIRNER G; DEKANT W; GUENGERICH FP
      THE SULFOXIDATION OF THE HEXACHLOROBUTADIENE METABOLITE TYL-S-(1,2,3,4,4-PENTACHLOROBUTADIENYL)-L-CYSTEINE IS CATALYZED BY HUMAN CYTOCHROME-P450 3A ENZYMES

      Chemical research in toxicology
    64. WILNER KD; GARDNER MJ
      TENIDAP SODIUM DOES NOT ALTER THE CLEARANCE OR PLASMA-PROTEIN BINDINGOF TOLBUTAMIDE IN HEALTHY MALE-VOLUNTEERS

      British journal of clinical pharmacology
    65. GEORGE J; MURRAY M; BYTH K; FARRELL GC
      DIFFERENTIAL ALTERATIONS OF CYTOCHROME-P450 PROTEINS IN LIVERS FROM PATIENTS WITH SEVERE CHRONIC LIVER-DISEASE

      Hepatology
    66. LIN LY; KUMAGAI Y; HIRATSUKA A; NARIMATSU S; SUZUKI T; FUNAE Y; DISTEFANO EW; CHO AK
      CYTOCHROME P4502D ISOZYMES CATALYZE THE 4-HYDROXYLATION OF METHAMPHETAMINE ENANTIOMERS

      Drug metabolism and disposition
    67. GUENGERICH FP; OKAZAKI O; SETO Y; MACDONALD TL
      RADICAL-CATION INTERMEDIATES IN N-DEALKYLATION REACTIONS

      Xenobiotica
    68. OBERMEIER MT; WHITE RE; YANG CS
      EFFECTS OF BIOFLAVONOIDS ON HEPATIC P450 ACTIVITIES

      Xenobiotica
    69. BALDWIN SJ; BLOOMER JC; SMITH GJ; AYRTON AD; CLARKE SE; CHENERY RJ
      KETOCONAZOLE AND SULFAPHENAZOLE AS THE RESPECTIVE SELECTIVE INHIBITORS OF P4503A AND 2C9

      Xenobiotica
    70. LASLETT TJ; ALVAREZ F; NATION RL; EVANS AM; SCOTT SD; STUPANS I
      EFFECT OF CYCLOPHOSPHAMIDE ADMINISTRATION ON THE ACTIVITY AND RELATIVE CONTENT OF HEPATIC P4502D1 IN RAT

      Xenobiotica
    71. WATSON ADJ; CHURCH DB; EMSLIE DR; BAGGOT JD; GRIFFIN DL
      EFFECT OF INGESTA AND OF TABLETS OF DIFFERENT STRENGTHS ON THE SYSTEMIC AVAILABILITY OF DIGOXIN IN NORMAL DOGS

      Research in Veterinary Science
    72. CRUMB WJ; WIBLE B; ARNOLD DJ; PAYNE JP; BROWN AM
      BLOCKADE OF MULTIPLE HUMAN CARDIAC POTASSIUM CURRENTS BY THE ANTIHISTAMINE TERFENADINE - POSSIBLE MECHANISM FOR TERFENADINE-ASSOCIATED CARDIOTOXICITY

      Molecular pharmacology
    73. CARACO Y; TATEISHI T; WOOD AJJ
      INTERETHNIC DIFFERENCE IN OMEPRAZOLES INHIBITION OF DIAZEPAM METABOLISM

      Clinical pharmacology and therapeutics
    74. SAKAMOTO K; KIRITA S; BABA T; NAKAMURA Y; YAMAZOE Y; KATO R; TAKANAKA A; MATSUBARA T
      A NEW CYTOCHROME-P450 FORM BELONGING TO THE CYP2D IN DOG LIVER-MICROSOMES - PURIFICATION, CDNA CLONING, AND ENZYME CHARACTERIZATION

      Archives of biochemistry and biophysics
    75. GILLAM EMJ; GUO ZY; MARTIN MV; JENKINS CM; GUENGERICH FP
      EXPRESSION OF CYTOCHROME-P450 2D6 IN ESCHERICHIA-COLI, PURIFICATION, AND SPECTRAL AND CATALYTIC CHARACTERIZATION

      Archives of biochemistry and biophysics
    76. LEE CA; KADWELL SH; KOST TA; SERABJITSINGH CJ
      CYP3A4 EXPRESSED BY INSECT CELLS INFECTED WITH A RECOMBINANT BACULOVIRUS CONTAINING BOTH CYP3A4 AND HUMAN NADPH-CYTOCHROME P450 REDUCTASE IS CATALYTICALLY SIMILAR TO HUMAN LIVER MICROSOMAL CYP3A4

      Archives of biochemistry and biophysics
    77. GILLAM EMJ; GUO ZY; UENG YF; YAMAZAKI H; COCK I; REILLY PEB; HOOPER WD; GUENGERICH FP
      EXPRESSION OF CYTOCHROME-P450-3A5 IN ESCHERICHIA-COLI - EFFECTS OF 5'MODIFICATION, PURIFICATION, SPECTRAL CHARACTERIZATION, RECONSTITUTIONCONDITIONS, AND CATALYTIC ACTIVITIES

      Archives of biochemistry and biophysics
    78. GUENGERICH FP
      INFLUENCE OF NUTRIENTS AND OTHER DIETARY MATERIALS ON CYTOCHROME-P-450 ENZYMES

      The American journal of clinical nutrition
    79. GOLDSTEIN JA; DEMORAIS SMF
      BIOCHEMISTRY AND MOLECULAR-BIOLOGY OF THE HUMAN CYP2C SUBFAMILY

      Pharmacogenetics
    80. YASUMORI T; LI QH; YAMAZOE Y; UEDA M; TSUZUKI T; KATO R
      LACK OF LOW K-M DIAZEPAM N-DEMETHYLASE IN LIVERS OF POOR METABOLIZERSFOR S-MEPHENYTOIN 4'-HYDROXYLATION

      Pharmacogenetics
    81. KATO R; YAMAZOE Y
      THE IMPORTANCE OF SUBSTRATE CONCENTRATION IN DETERMINING CYTOCHROMES P450 THERAPEUTICALLY RELEVANT IN-VIVO

      Pharmacogenetics
    82. DEMEY C; MEINEKE I; STEINIJANS VW; HUBER R; HARTMANN M; BLIESATH H; WURST W
      PANTOPRAZOLE LACKS INTERACTION WITH ANTIPYRINE IN MAN, EITHER BY INHIBITION OR INDUCTION

      International journal of clinical pharmacology and therapeutics
    83. OHMORI S; KUDO S; NAKASA H; HORIE T; KITADA M
      PURIFICATION AND CHARACTERIZATION OF CYTOCHROME-P450 3A ENZYME FROM HEPATIC MICROSOMES OF UNTREATED DOGUERA BABOONS

      Biological & pharmaceutical bulletin
    84. INOUE K; INAZAWA J; SUZUKI Y; SHIMADA T; YAMAZAKI H; GUENGERICH FP; ABE T
      FLUORESCENCE IN-SITU HYBRIDIZATION ANALYSIS OF CHROMOSOMAL LOCALIZATION OF 3 HUMAN CYTOCHROME-P450-2C GENES (CYP2C8, 2C9, AND 2C10) AT 10Q24.1

      Japanese journal of human genetics
    85. OGURI K; YAMADA H; YOSHIMURA H
      REGIOCHEMISTRY OF CYTOCHROME-P450 ISOZYMES

      Annual review of pharmacology and toxicology
    86. KITADA M; KAMATAKI T
      CYTOCHROME-P450 IN HUMAN FETAL LIVER - SIGNIFICANCE AND FETAL-SPECIFIC EXPRESSION

      Drug metabolism reviews
    87. FUCHS W; SENNEWALD R; KLOTZ U
      LANSOPRAZOLE DOES NOT AFFECT THE BIOAVAILABILITY OF ORAL-CONTRACEPTIVES

      British journal of clinical pharmacology
    88. ROST KL; BROSICKE H; HEINEMEYER G; ROOTS I
      SPECIFIC AND DOSE-DEPENDENT ENZYME-INDUCTION BY OMEPRAZOLE IN HUMAN-BEINGS

      Hepatology
    89. ROST KL; BROSICKE H; HEINEMEYER G; ROOTS I
      SPECIFIC AND DOSE-DEPENDENT ENZYME-INDUCTION BY OMEPRAZOLE IN HUMAN-BEINGS

      Hepatology
    90. TUCKER GT
      THE INTERACTION OF PROTON PUMP INHIBITORS WITH CYTOCHROMES P450

      Alimentary pharmacology & therapeutics
    91. JORQUERA F; MARTINEZ C; GONZALEZSASTRE M; CULEBRAS JM; GONZALEZGALLEGO J
      ANTIPYRINE CLEARANCE IN SURGICAL PATIENTS MAINTAINED ON HYPOCALORIC PERIPHERAL PARENTERAL-NUTRITION

      JPEN. Journal of parenteral and enteral nutrition
    92. EARLSALOTTI GL; CHARLAND SL
      THE EFFECT OF PARENTERAL-NUTRITION ON HEPATIC CYTOCHROME-P-450

      JPEN. Journal of parenteral and enteral nutrition
    93. YAMAZAKI H; MIMURA M; ODA Y; GONZALEZ FJ; ELBAYOUMY K; CHAE YH; GUENGERICH FP; SHIMADA T
      ACTIVATION OF TRANS-1,2-DIHYDRO-1,2-DIHYDROXY-6-AMINOCHRYSENE TO GENOTOXIC METABOLITES BY RAT AND HUMAN CYTOCHROMES P450

      Carcinogenesis
    94. SHIMADA T; GILLAM EMJ; SANDHU P; GUO ZY; TUKEY RH; GUENGERICH FP
      ACTIVATION OF PROCARCINOGENS BY HUMAN CYTOCHROME-P450 ENZYMES EXPRESSED IN ESCHERICHIA-COLI - SIMPLIFIED BACTERIAL SYSTEMS FOR GENOTOXICITYASSAYS

      Carcinogenesis
    95. NAIDU MUR; SHOBHA JC; DIXIT VK; KUMAR A; SEKHAR KR; SEKHAR EC; KUMAR TR
      EFFECT OF MULTIPLE-DOSE OMEPRAZOLE ON THE PHARMACOKINETICS OF CARBAMAZEPINE

      Drug investigation
    96. HARRELL AW; WHEELER SM; EAST P; CLARKE SE; CHENERY RJ
      USE OF RAT AND HUMAN IN-VITRO SYSTEMS TO ASSESS THE EFFECTIVENESS ANDENZYMOLOGY OF DEOXYGUANINE ANALOGS AS PRODRUGS OF AN ANTIVIRAL AGENT

      Drug metabolism and disposition
    97. HARRELL AW; WHEELER SM; EAST P; CLARKE SE; CHENERY RJ
      USE OF RAT AND HUMAN IN-VITRO SYSTEMS TO ASSESS THE EFFECTIVENESS ANDENZYMOLOGY OF DEOXY-GUANINE ANALOGS AS PRODRUGS OF AN ANTIVIRAL AGENT

      Drug metabolism and disposition
    98. NEDELCHEVA V; GUT I
      P450 IN THE RAT AND MAN - METHODS OF INVESTIGATION, SUBSTRATE SPECIFICITIES AND RELEVANCE TO CANCER

      Xenobiotica
    99. HALPERT JR; GUENGERICH FP; BEND JR; CORREIA MA
      SELECTIVE INHIBITORS OF CYTOCHROMES P450

      Toxicology and applied pharmacology
    100. YAMAZAKI H; GUO ZY; PERSMARK M; MIMURA M; INOUE K; GUENGERICH FP; SHIMADA T
      BUFURALOL HYDROXYLATION BY CYTOCHROME-P450 2D6 AND 1A2 ENZYMES IN HUMAN LIVER-MICROSOMES

      Molecular pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 21:32:17